Human Internal BIOASTER's Samples Collection

NCT06602388 | Not Yet Recruiting

• 1 other identifier: 2024-A00323-44
• Study Type: observational
• Target: 120
• Locations: 0 countries
• Sites: N/A

Brief Summary

BIOASTER is a Technological Research Institute dedicated to microbiology and infectious diseases. BIAOSTER s areas of expertise are organized around four research programs: 1/ Antimicrobials; 2/ Vaccines; 3/ Microbiota; 4/ Diagnostics. Hibiscus is a non-interventional, monocentric study aimed at building up a a collection of biological samples (stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair) collected from BIOASTER employees. These samples to be used for scientific purposes including the technological development of Bioaster s collaborative and in-house research projects.

Conditions

Biological Samples

Keywords

Biological; samples; collection

Outcome Measures

Primary Outcomes (1)

• The number of analyzable samples collected for scientific purposes.

  The number of analyzable samples collected for scientific purposes at the end of inclusion periode

  3 years after the first inclusion

Study Arms (1)

Healthy volunteers (Bioaster employees)

Collection of biological samples from healthy volunteers: Stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair

Other: Biological sampling

Interventions

Biological sampling OTHER

Collection of biological samples from healthy volunteers: Stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair

Healthy volunteers (Bioaster employees)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Healthy volunteers (Bioaster employees)

You may qualify if:

• Age criteria (e.g.: specific, non-identifying range sought: 30-40 years)
• BMI criteria (for example: BMI between 18.5 and 29 kg/m2)
• Gender criteria (e.g.: women only)

You may not qualify if:

• Minor subject
• Health criteria (e.g. presence or absence illness/infection/vaccination/allergy/anti-infective treatment in the last 3 months prior to the date of sampling)
• Smoker status
• Severe chronic illness (active cancer, HIV, severe renal failure, ongoing severe heart, liver or biliary disorders, arthritis)
• Diagnosed acute or chronic gastrointestinal disease or complication (e.g. celiac disease, gastroesophageal reflux, gastric or duodenal ulcer, Crohn\'s disease, hemorrhoids, irritable bowel syndrome),
• In all cases, it will be requested that volunteers with the following criteria do not participate in the study:
• Pregnant or breast-feeding women
• Subjects under curatorship or guardianship
• Subjects under legal protection.

Sponsors & Collaborators

• Bioaster: lead

Biospecimen

Retention: SAMPLES WITHOUT DNA

biological samples: stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair

Study Officials

• Cyril GUYARD, Study Director

  Bioaster

  STUDY DIRECTOR

• Dr Xavier MORGE

  Bioaster

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Karima BRAHAMI-AISSOU

CONTACT

+336 34 53 37 84; karima.brahami-aissou@bioaster.org

Marie KOENIG

CONTACT

+33 4 81 11 37 42; marie.koenig@bioaster.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 16, 2024
• First Posted: September 19, 2024
• Study Start: December 30, 2024
• Primary Completion (Estimated): December 31, 2027
• Study Completion (Estimated): December 31, 2027
• Last Updated: September 20, 2024

Record last verified: 2024-09

Data Sharing

• IPD Sharing: Will not share